References
- Mukherjee AB, Zhang Z, Chilton BS. Uteroglobin: a steroid-inducible immunomodulatory protein that founded the Secretoglobin superfamily. Endocr Rev 2007;28:707–25
- Lee YC, Zhang Z, Mukherjee AB. Mice lacking uteroglobin are highly susceptible to developing pulmonary fibrosis. FEBS Lett 2006;580:4515–20
- Yong D, QingQing W, Hua L, et al. Association of uteroglobin G38A polymorphism with IgA nephropathy: a meta-analysis. Am J Kidney Dis 2006;48:1–7
- Hastings MC, Moldoveanu Z, Suzuki H, et al. Biomarkers in IgA nephropathy: relationship to pathogenetic hits. Expert Opin Med Diagn 2013;7:615–27
- Canetta PA, Kiryluk K, Appel GB. Glomerular diseases: emerging tests and therapies for IgA nephropathy. Clin J Am Soc Nephrol 2014;9:617–25
- Zhou TB, Yin SS. Association of matrix metalloproteinase-9 level with the risk of renal involvement for Henoch-Schonlein purpura in children. Ren Fail 2013;35:425–9
- Zhou TB, Yin SS, Liang R. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients. J Renin Angiotensin Aldosterone Syst 2013;14:235–41
- Cheng HY, You HY, Zhou TB. Relationship between GSTM1/GSTT1 null genotypes and renal cell carcinoma risk: a meta-analysis. Ren Fail 2012;34:1052–7
- Zhou TB, Qin YH, Xu HL. Association of apoE gene expression and its gene polymorphism with nephrotic syndrome susceptibility: a meta-analysis of experimental and human studies. Mol Biol Rep 2012;39:9347–54
- Zhou TB, Yin SS. Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease. Ren Fail 2013;35:573–8
- Zhou TB, Yin SS, Jiang ZP. Association of angiotensin II type-1 receptor A1166C gene polymorphism with the susceptibility of end-stage renal disease. J Recept Signal Transduct Res 2013;33:325–31
- Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–101
- Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34
- Kim YS, Kang D, Kwon DY, et al. Uteroglobin gene polymorphisms affect the progression of immunoglobulin A nephropathy by modulating the level of uteroglobin expression. Pharmacogenetics 2001;11:299–305
- Lim CS, Kim SM, Oh YK, et al. Association between the clara cell secretory protein (CC16) G38A polymorphism and the progression of IgA nephropathy. Clin Nephrol 2007;67:73–80
- Lu JC, Zhang H, Chen YQ, et al. Uteroglobin G38A polymorphism is associated with the progression of IgA nephropathy in Chinese patients. Zhonghua Nei Ke Za Zhi 2004;43:37–40
- Matsunaga A, Numakura C, Kawakami T, et al. Association of the uteroglobin gene polymorphism with IgA nephropathy. Am J Kidney Dis 2002;39:36–41
- Menegatti E, Nardacchione A, Alpa M, et al. Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathy. Lab Invest 2002;82:543–6
- Narita I, Saito N, Goto S, et al. Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients. Kidney Int 2002;61:1853–8
- Szelestei T, Bahring S, Kovacs T, et al. Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy. Am J Kidney Dis 2000;36:468–73